Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma.

about

MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.

P2860

Q55439547-8AC97E43-9EAC-4A16-988E-366A2CFB3786

P2860

Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma.

Item

http://www.wikidata.org/entity/Q41342755

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cbl-b predicts postoperative s ...... creatic ductal adenocarcinoma.

@en

type

Item

label

Cbl-b predicts postoperative s ...... creatic ductal adenocarcinoma.

@en

prefLabel

Cbl-b predicts postoperative s ...... creatic ductal adenocarcinoma.

@en

P1476

Cbl-b predicts postoperative s ...... creatic ductal adenocarcinoma.

@en

P2093

Ce Li

http://www.w3.org/2001/XMLSchema#string

Kai Li

http://www.w3.org/2001/XMLSchema#string

Qian Dong

http://www.w3.org/2001/XMLSchema#string

Xianghong Yang

http://www.w3.org/2001/XMLSchema#string

Xiaofang Che

http://www.w3.org/2001/XMLSchema#string

Xiujuan Qu

http://www.w3.org/2001/XMLSchema#string

Yafei Qi

http://www.w3.org/2001/XMLSchema#string

Yao Zhang

http://www.w3.org/2001/XMLSchema#string

Yunpeng Liu

http://www.w3.org/2001/XMLSchema#string

Yuteng Ma

http://www.w3.org/2001/XMLSchema#string

P2860

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

cbl-b inhibits epidermal growth factor receptor signaling

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

P304

57163-57173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18714

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28915662

http://www.w3.org/2001/XMLSchema#string

P932

5593633

http://www.w3.org/2001/XMLSchema#string

Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma.

about

P2860

P2860

Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932